Loomis, Sayles & Company’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-272,158
Closed -$18.3M 994
2023
Q1
$18.3M Sell
272,158
-1,134
-0.4% -$89.1K 0.03% 247
2022
Q4
$20.9M Buy
273,292
+46,989
+21% +$3.49M 0.04% 221
2022
Q3
$18.2M Sell
226,303
-2,189
-1% -$208K 0.04% 221
2022
Q2
$20.2M Sell
228,492
-1,701
-0.7% -$178K 0.04% 244
2022
Q1
$30.6M Buy
230,193
+7,305
+3% +$920K 0.04% 222
2021
Q4
$37.4M Sell
222,888
-2,318
-1% -$359K 0.05% 219
2021
Q3
$30.6M Buy
225,206
+6,273
+3% +$810K 0.04% 246
2021
Q2
$24.8M Buy
218,933
+8,632
+4% +$835K 0.03% 271
2021
Q1
$17.8M Buy
+210,301
New +$17.6M 0.02% 306

Other funds holding DAVA

Loomis, Sayles & Company's DAVA Position: Q2 2023 in Review

Loomis, Sayles & Company sold out of Endava (DAVA) in Q2 2023, closing a stake of 272,158 shares — an estimated $18.3M sold.

Loomis, Sayles & Company first reported a position in DAVA in Q1 2021 and held it in 9 quarters. The position peaked at $37.4M in Q4 2021. 160 funds tracked by Wall St. Rank hold DAVA as of Q2 2023.

  • Loomis, Sayles & Company reported no remaining Endava position as of Q2 2023 after selling out during the quarter.
  • Loomis, Sayles & Company sold 272,158 Endava shares in Q2 2023, an estimated $18.3M.
  • Loomis, Sayles & Company first reported a position in Endava in Q1 2021 and held it in 9 quarters.
  • Loomis, Sayles & Company's Endava position peaked at $37.4M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Endava as of Q2 2023.

Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.